BEAMSTART Logo

The King of Ozempic Is Scared as Hell

Wired LogoWired2d ago

The King of Ozempic Is Scared as Hell - Wired

Quick Summary:

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Jørgensen told the committee, “We lowered the list price in the US by 65 percent, just to realize that after we dropped the price of Levemir, the PBMs dropped coverage.” Novo discontinued the drug.

Without those pens, type 1 diabetics had to resort to cumbersome vials.(A spokesperson at the time said Novo was phasing out certain products to address “capacity constraints.“This is completely unacceptable,” Helen Bygrave, of Doctors Without Borders, told me.“More lucrative medicines in the same pen devices—GLP-1s like Ozempic and Wegovy—are being sold by Novo at an unprecedented rate in high-income countries.


More Pictures

The King of Ozempic Is Scared as Hell - Wired (Picture 1)The King of Ozempic Is Scared as Hell - Wired (Picture 2)The King of Ozempic Is Scared as Hell - Wired (Picture 3)The King of Ozempic Is Scared as Hell - Wired (Picture 4)The King of Ozempic Is Scared as Hell - Wired (Picture 5)

or

Article Details

Author / Journalist: Virginia Heffernan

Category: TechnologyEconomy

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-01-13 @ 11:00:00 (2 days ago)

News Timezone: GMT +8:00

News Source URL: wired.com

Language: English

Article Length: 5497 words

Reading Time: 31 minutes read

Sentences: 270 lines

Sentence Length: 21 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Wired

News ID: 25104740

View Article Analysis

About Wired

Main Topics: TechnologyEconomy

Official Website: wired.com

Update Frequency: 11 posts per day

Year Established: 1993

Headquarters: United States

News Last Updated: 17 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #111

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "The King of Ozempic Is Scared as Hell" has 5497 words across 270 sentences, which will take approximately 23 - 46 minutes for the average person to read.

Which news outlet covered this story?

The story "The King of Ozempic Is Scared as Hell" was covered 2 days ago by Wired, a news publisher based in United States.

How trustworthy is 'Wired' news outlet?

Wired is a fully independent (privately-owned) news outlet established in 1993 that covers mostly technology and economy news.

The outlet is headquartered in United States and publishes an average of 11 news stories per day.

It's most recent story was published 17 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #25104740
  • URL: https://beamstart.com/news/the-king-of-ozempic-is-17367694666870

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.